retatrutide oral (RETA) is one of the most promising investigational peptides in obesity research—but one important question deserves more attention: Can it affect birth control? Current evidence shows that GLP-1 receptor agonists slow retatrutide what is retatrutide clinical
Description
Am I prepared for potential side effects, which can include nausea, vomiting, diarrhea, and other gastrointestinal symptoms

doi: 10.1210/jc.2009-0366 [DOI] [PubMed] [Google Scholar] 124

When can I expect to feel less hungry after starting GLP-1

Contact your doctor if it persists or if you have existing kidney issues

Emerging Research: Combination Strategies for the Hallmarks of Aging While GLP-1s have attracted attention for their metabolic and cardiometabolic effects, aging biology suggests that no single intervention is likely to address all hallmarks simultaneously

Inflammatory biomarkers and psychological variables to assess quality of life in patients with inflammatory bowel disease: a cross-sectional study
